Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Featured Company: Is 3SBio Too Conservative?

publication date: Jul 1, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

In seventeen months, 3SBio has gone from a well-received IPO to a company announcing a stock buyback to lift its stock price.  What happened?  Even though it has very strong financials, investors are not interested.  Meanwhile, the company is sitting on a large pile of IPO cash. Is 3SBio willing to do something dramatic to interest investors?  We take a look...

Stock Symbols: (NSDQ: SSRX) (NSDQ: AMGN) (NSDQ: AMAG) 




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors